NUVILEX, INC. (NVLX)

Sorry, no known transcripts

Recent filings

Sabby Volatility Warrant Master Fund, Ltd. just provided an update on share ownership of NUVILEX, INC. - Jan. 10, 2023

NUVILEX, INC. director was just granted 125,000 options - Dec. 30, 2022

Submission of Matters to a Vote of Security - Dec. 30, 2022

NUVILEX, INC. director was just granted 125,000 options - Dec. 30, 2022

NUVILEX, INC. director just declared ownership of no shares of NUVILEX, INC. - Dec. 30, 2022

NUVILEX, INC. Just Filed Its Quarterly Report: NOTE 10 – EARNINGS P... - Dec. 14, 2022

NUVILEX, INC. releases salary data. CEO sees compensation rise 49% - Nov. 25, 2022

Departure of Directors or Certain - Nov. 18, 2022

NUVILEX, INC. director just declared ownership of no shares of NUVILEX, INC. - Nov. 16, 2022

Other preliminary proxy statements - Nov. 15, 2022

Departure of Directors or Certain - Nov. 7, 2022

Shay Capital Holdings LLC just provided an update on share ownership of NUVILEX, INC. - Oct. 20, 2022

NUVILEX: This Release Agreement (“ Release - Oct. 14, 2022

NUVILEX: Pharmacyte Biotech Board Of Directors Announces Business Review Committee To Evaluate Opportunities To Optimize Shareholder Value - Oct. 7, 2022

NUVILEX, INC. Just Filed Its Quarterly Report: NOTE 10 – EARNINGS P... - Sept. 14, 2022

NUVILEX, INC. director just declared owning 260,000 shares of NUVILEX, INC. - Aug. 24, 2022

NUVILEX, INC. director just declared ownership of no shares of NUVILEX, INC. - Aug. 23, 2022

NUVILEX, INC. director just declared owning 50,000 shares of NUVILEX, INC. - Aug. 23, 2022

NUVILEX, INC. director just declared owning 714,570 shares of NUVILEX, INC. - Aug. 23, 2022

NUVILEX, INC. director just declared owning 50,000 shares of NUVILEX, INC. - Aug. 23, 2022

Jude C. Uzonwanne just provided an update on activist position in NUVILEX, INC. - Aug. 15, 2022

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - July 28, 2022

NUVILEX: Pharmacyte Biotech Rebukes Iroquois’ Commencement Of Consent Solicitation - July 28, 2022

NUVILEX: Pharmacyte Biotech Rebukes Iroquois’ Commencement Of Consent Solicitation - July 28, 2022

NUVILEX, INC. Just Filed Its Annual Report: NOTE 11 – EARNINGS P... - July 28, 2022

Preliminary proxy statements, contested solicitations - July 26, 2022

NUVILEX: Pharmacyte Biotech Commences First Phase Of Two-Phase Pig Study - July 21, 2022

NUVILEX: Pharmacyte Biotech Commences First Phase Of Two-Phase Pig Study - July 21, 2022

NUVILEX: Pharmacyte Biotech Reports Positive Interim Results In Malignant Ascites Mouse Model Study - July 19, 2022

NUVILEX: Pharmacyte Biotech Reports Positive Interim Results In Malignant Ascites Mouse Model Study - July 19, 2022

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - July 11, 2022

NUVILEX: Pharmacyte Biotech Announces Preliminary Unaudited Financial Results - July 11, 2022

NUVILEX: Pharmacyte Biotech Announces Preliminary Unaudited Financial Results - July 11, 2022

Jude C. Ozonwanne just provided an update on activist position in NUVILEX, INC. - July 11, 2022

Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - July 5, 2022

NUVILEX: Pharmacyte Biotech Issues Follow-Up Response To Iroquois Capital’S Second Letter On June 9 And Reiterates Commitment To Increasing Shareholder Value - June 15, 2022

NUVILEX: Pharmacyte Biotech Issues Follow-Up Response To Iroquois Capital’S Second Letter On June 9 And Reiterates Commitment To Increasing Shareholder Value - June 15, 2022

Shareholder Director - June 7, 2022

Departure of Directors or Certain - April 13, 2022

NUVILEX, INC. director just declared owning 3,004 shares of NUVILEX, INC. - April 11, 2022

NUVILEX: Pharmacyte Biotech Appoints Dr. Matthias Löhr To Board Of Directors - April 5, 2022

NUVILEX, INC. Just Filed Its Quarterly Report: NOTE 11 – EARNINGS (... - March 15, 2022

NUVILEX: Trial Design Oncologists Leading Experts In Development Of Therapies To Treat Pancreatic Cancer 19 Dr. Daniel D. Von Hoff Dr. Manuel Hidalgo Dr. Matthias Löhr - March 9, 2022

 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - March 1, 2022

 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Feb. 17, 2022

Statement of acquisition of beneficial ownership by individuals - Feb. 11, 2022

Sabby Volatility Warrant Master Fund, Ltd. just provided an update on share ownership of NUVILEX, INC. - Jan. 4, 2022

NUVILEX, INC. Just Filed Its Quarterly Report: NOTE 11 – EARNINGS (... - Dec. 14, 2021

NUVILEX, INC. just filed a prospectus, suggesting it plans to soon issue some securities - Nov. 22, 2021

Notice of Effectiveness - Nov. 17, 2021

Registration statement under Securities Act of 1933 - Nov. 8, 2021

Kimberly Page just provided an update on activist position in NUVILEX, INC. - Nov. 4, 2021

NUVILEX, INC. Just Filed Its Quarterly Report: NOTE 11 – EARNINGS P... - Sept. 14, 2021

NUVILEX: Presentation Of Pharmacyte Biotech, Inc - Sept. 10, 2021

NUVILEX, INC.'s CFO just declared owning 8,800 shares of NUVILEX, INC. - Sept. 3, 2021

Notice of Exempt Offering of Securities, item 06b - Sept. 1, 2021

Chairman of NUVILEX, INC. just declared owning 20,600 shares of NUVILEX, INC. - Aug. 31, 2021

NUVILEX, INC.'s Chief Science Officer just declared owning 11,200 shares of NUVILEX, INC. - Aug. 31, 2021

NUVILEX, INC. director just declared owning 1,667 shares of NUVILEX, INC. - Aug. 31, 2021

Sabby Volatility Warrant Master Fund, Ltd. just provided an update on share ownership of NUVILEX, INC. - Aug. 30, 2021

Intracoastal Capital LLC just provided an update on share ownership of NUVILEX, INC. - Aug. 30, 2021

NUVILEX, INC. just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 23, 2021

NUVILEX: Pharmacyte Biotech Announces $70 Million Registered Direct Offering - Aug. 23, 2021

NUVILEX, INC. director just declared owning 1,333 shares of NUVILEX, INC. - Aug. 20, 2021

NUVILEX, INC. director just declared owning 2,467 shares of NUVILEX, INC. - Aug. 20, 2021

NUVILEX, INC. director just declared owning 1,667 shares of NUVILEX, INC. - Aug. 20, 2021

Registration adding securities to prior Form S-3 registration [Rule 462(b)] - Aug. 19, 2021

NUVILEX: Press Release Dated August 9, 2021 - Aug. 12, 2021

Certification by an exchange approving securities for listing - Aug. 10, 2021

NUVILEX, INC. Just Filed Its Annual Report: NOTE 11 – EARNINGS P... - Aug. 10, 2021

NUVILEX, INC. just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 10, 2021

NUVILEX, INC. just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 2, 2021

On August - Aug. 2, 2021

Registration of securities [Section 12(b)] - Aug. 2, 2021

Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 - July 29, 2021

NUVILEX: Pharmacyte Biotech Announces Reverse Stock Split - July 13, 2021

NUVILEX: Amendment To Certificate Of Incorporation - July 6, 2021

Current report, items 8.01 and 9.01 - June 22, 2021

Current report, items 8.01 and 9.01 - June 15, 2021

Current report, items 8.01 and 9.01 - June 4, 2021

Current report, items 8.01 and 9.01 - May 6, 2021

Notice of Effectiveness - April 14, 2021

Registration statement under Securities Act of 1933 - April 5, 2021

Quarterly report [Sections 13 or 15(d)] - March 12, 2021

Quarterly report [Sections 13 or 15(d)] - Dec. 11, 2020

Sorry, no schedule available for this company

 


Feedback